Norway· NO-ID_F4F689D4-3474-486B-9F26-BE66B42430D3

Midamor

A amiloride product containing amilorid, registered in Norway by AA Pharma. The same ATC class is registered in 5 of our 19 countries.

ATC C03DB01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMidamorATCC03DB01REGISTER NO.NO-ID_F4F689D4-3474-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Amiloride is registered in 5 of 19 countries.

Countries holding a registration under ATC C03DB01 (amiloride), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Amiloride · ATC C03DB01

5 / 19 countries

  • Canada
  • Finlandprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Amilorid
Manufacturer
AA Pharma
Country
Norway (NO)
ATC code
C03DB01
ATC class
Amiloride
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_F4F689D4-3474-486B-9F26-BE66B42430D3
  • no_varenummer
    247643
    100

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

238 interactions on record for amiloride.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Amiloride · interactions on record

238 records

  • 7 severe
  • 115 moderate
  • 7 minor
  • 32 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

77 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amiloride in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amiloride products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Cyprus · Alverix, Amiloride Accord Healthcare
  • France · Modamide
  • United Kingdom (Northern Ireland) · Amiloride, Amiloride Accord Healthcare

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa6c65d5-9f83-46ee-87ec-dee23501034e
GET /v1/drugs/aa6c65d5-9f83-46ee-87ec-dee23501034e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Amilorid",
  "merkevare_id": "ID_F4F689D4-3474-486B-9F26-BE66B42430D3",
  "name_form_strength": "Midamor tab 5 mg",
  "prescription_group": "C"
}

See everything about amiloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.